GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genomed SA (WAR:GEN) » Definitions » YoY EPS Growth

Genomed (WAR:GEN) YoY EPS Growth : 436.00% (As of Sep. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Genomed YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Genomed's YoY EPS Growth for the quarter that ended in Sep. 2024 was 436.00%.

Genomed's Earnings per Share (Diluted) for the three months ended in Sep. 2024 was zł0.27.

Genomed YoY EPS Growth Historical Data

The historical data trend for Genomed's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomed YoY EPS Growth Chart

Genomed Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -32.32 -58.84 200.32 -72.68 173.83

Genomed Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -69.14 154.87 -323.64 42.92 436.00

Genomed YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Genomed's YoY EPS Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EPS Growth (A: Dec. 2023 )
=(Earnings per Share (Diluted) (A: Dec. 2023 )-Earnings per Share (Diluted) (A: Dec. 2022 ))/ | Earnings per Share (Diluted) (A: Dec. 2022 ) |
=(0.701-0.256)/ | 0.256 |
=173.83 %

Genomed's YoY EPS Growth for the quarter that ended in Sep. 2024 is calculated as:

YoY EPS Growth (Q: Sep. 2024 )
=(Earnings per Share (Diluted) (Q: Sep. 2024 )-Earnings per Share (Diluted) (Q: Sep. 2023 )) / | Earnings per Share (Diluted) (Q: Sep. 2023 )) |
=(0.268-0.05)/ | 0.05 |
=436.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genomed YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Genomed's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Genomed Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genomed SA (WAR:GEN) » Definitions » YoY EPS Growth
Comparable Companies
WAR:BMX WAR:IGN TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN LH DGX WAT XPAR:BIM EXAS RVTY XPAR:ERF ASX:SHL
Traded in Other Exchanges
N/A
Address
Ulica Ponczowa 12, Warszawa, POL, 02-971
Website
http://www.genomed.pl
Genomed SA assembles outstanding molecular biologists and genetic diagnosticians. The company provides diagnostic service that comprises DNA analysis and congenital diseases diagnostics based on DNA sequencing. It offers Diagnostic service and Service for scientific purposes.